BRIDGEWATER, N.J., Oct 29, 2008 /PRNewswire-FirstCall via COMTEX/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) (insulin glulisine [rDNA origin] injection) to improve glycemic control in children (4 years and older) with diabetes mellitus.
The approval of Apidra(R) for pediatric use is based upon FDA review of a 26-week, phase III, open-label, active control study of Apidra(R) in comparison with insulin lispro, in 572 children and adolescents (4... read more
Submitted by Avera
DANVILLE, PA - The use of an antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis, new Geisinger research shows.
Researchers examined the records of 2,093 Geisinger patients who received treatment for rheumatoid arthritis from 2000 to 2008. The study looked at, among other things, use of the medication hydroxychloroquine (HCQ) and the development of new cases of diabetes in these patients.
HCQ was developed to treat malaria but... read more
Submitted by Avera
TUESDAY, Oct. 28 (HealthDay News) -- While millions of Americans are at risk for developing diabetes, too few perceive the threat it can pose to their health, according to a new survey.
In fact, most respondents feared shark bites, plane crashes or cancer more, even though they are more likely to get diabetes, according to the pollsters.
"We undertook the survey because we are trying to better understand why people aren't taking diabetes as seriously... read more
Submitted by Avera
NEW YORK (Reuters Health) - Drinking moderate amounts of alcohol may protect women from developing type 2 diabetes, but the effect of alcohol on inflammation and blood vessel function doesn't appear to explain the relationship, new research suggests.
Dr. Joline W. J. Beulens of University Medical Center Utrecht, The Netherlands, and colleagues found that adiponectin -- a hormone secreted by fatty tissue that regulates how the body uses fat and glucose (sugar) -- accounted for... read more
Submitted by Avera
NEW YORK (Reuters Health) - A 2-day in-hospital group program of diabetes education, followed by individual support sessions every 3 months, significantly helped prevent or delay progression to type 2 diabetes in adults with the pre-diabetic state called impaired glucose tolerance, Japanese researchers report.
Submitted by Avera
Solianis is conducting a study in which patients with diabetes are testing a preliminary functional model of the future device for non-invasive glucose monitoring. First results confirm the expected applicability of the multi-sensor platform in everyday life.
Submitted by BarryE